HAYWARD, Calif., July 18, 2011 /PRNewswire/ -- Solta Medical, Inc.
(NASDAQ: SLTM), a global leader in the medical aesthetics market,
today announced that it will release its financial results for the
second quarter ended June 30, 2011,
after market close on Tuesday, August 2,
2011. The Company will also host a conference call and
webcast on Tuesday, August 2, 2011,
at 4:30 p.m. Eastern Time
(1:30 p.m. Pacific) to discuss the
financial results and current corporate developments. The
dial-in number for the conference call is 877-941-0844 for domestic
participants and 480-629-9835 for international participants.
To access the live webcast of the call, go to Solta Medical's
website at www.solta.com and click on Investor Relations. An
archived webcast will also be available at www.solta.com.
About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics
market providing innovative, safe, and effective solutions for
patients that enhance and expand the practice of medical aesthetics
for physicians. The company offers products to address a range of
skin issues under the industry's four premier brands: Thermage®,
Fraxel®, Isolaz®, and CLARO®. Thermage is an innovative,
non-invasive radiofrequency procedure for tightening and contouring
skin. As the leader in fractional laser technology, Fraxel delivers
minimally invasive clinical solutions to resurface aging and sun
damaged skin. Isolaz is the only laser or light based system
indicated for the treatment of inflammatory acne, comedonal acne,
pustular acne, and mild-to-moderate inflammatory acne. CLARO is a
personal care acne system that is the first FDA cleared
over-the-counter IPL device that uses a powerful combination of
both heat and light to clear skin quickly and naturally. Since
2002, over one million Thermage, Fraxel and Isolaz procedures have
been performed in over 100 countries. For more information about
Solta Medical, call 1-877-782-2286 or log on to www.Solta.com.
SOURCE Solta Medical, Inc.